Thyroid Cancer Trial, Recruiting (NCT06333587)

Thyroid Cancer Trial, Recruiting NCT06333587 Sponsor: European Institute of Oncology Condition: Thyroid Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06333587 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Thyroid Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be over 18 years old
You must have been diagnosed with a small type of thyroid cancer called papillary thyroid microcarcinoma, confirmed by a cell sample test, and be suitable for a minimally invasive thermal treatment (MITT)
You must be willing and able to sign a written consent form before joining the trial
You must be able to attend follow-up appointments after the trial begins

Who may not be able to join:

Your tumor is larger than 1 cm, is a different type of thyroid cancer, or you are not suitable for the minimally invasive thermal treatment for any reason
You do not wish to have the minimally invasive thermal treatment
You have an uncontrollable blood clotting disorder
You have a psychiatric condition, addiction, or any other condition that affects your ability to fully understand and agree to take part in the study

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Giovanni Mauri, European Institute of Oncology

Phone: +390294372691

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06333587

Sponsor: European Institute of Oncology

Phase: Not Applicable

Status: Recruiting

Condition: Thyroid Cancer

Trial contact: +390294372691

More information: https://clinicaltrials.gov/study/NCT06333587

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be over 18 years old
You must have been diagnosed with a small type of thyroid cancer called papillary thyroid microcarcinoma, confirmed by a cell sample test, and be suitable for a minimally invasive thermal treatment (MITT)
You must be willing and able to sign a written consent form before joining the trial
You must be able to attend follow-up appointments after the trial begins

Who may not be able to join:

Your tumor is larger than 1 cm, is a different type of thyroid cancer, or you are not suitable for the minimally invasive thermal treatment for any reason
You do not wish to have the minimally invasive thermal treatment
You have an uncontrollable blood clotting disorder
You have a psychiatric condition, addiction, or any other condition that affects your ability to fully understand and agree to take part in the study

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

European Institute of Oncology

Registry

ClinicalTrials.gov

Start date

10 October 2022

Est. completion

31 December 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

The proportion of patients with major complications occurring within one month after the date of intervention

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov